Cytokinetics (CYTK) Earnings Date & Reports

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CYTK is expected to report earnings to rise 8.73% to -137 cents per share on May 01

Cytokinetics CYTK Stock Earnings Reports

Q1'25

Est.

$-1.37

Q4'24

Missed

by $0.04

Q3'24

Missed

by $0.13

Q2'24

Missed

by $0.25

Q1'24

Missed

by $0.19

The last earnings report on February 27 showed earnings per share of -125 cents, missing the estimate of -122 cents. With 487.58K shares outstanding, the current market capitalization sits at 4.77B.

View a ticker or compare two or three

Compare

CYTK